Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K5CJ
|
||||
Former ID |
DIB007914
|
||||
Drug Name |
DAVLB-HYDRAZIDE
|
||||
Synonyms |
Desacetylvinblastine-3-carboxyhydrazide; 3aalpha-Ethyl-9-[5alpha-ethyl-5beta-hydroxy-9beta-(methoxycarbonyl)-1,2,4,5,6,7beta,8,9-octahydro-10H-3,7-methanoazacycloundecino[5,4-b]indol-9alpha-yl)-4beta,5beta-dihydroxy-8-methoxy-6-methyl-3a,4,5
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [530726] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H14N2O4
|
||||
Canonical SMILES |
CC(=O)CCC1C(=O)NC(=O)N(C1=O)C2=CC=CC=C2
|
||||
InChI |
1S/C14H14N2O4/c1-9(17)7-8-11-12(18)15-14(20)16(13(11)19)10-5-3-2-4-6-10/h2-6,11H,7-8H2,1H3,(H,15,18,20)
|
||||
InChIKey |
WTMIEMJOWOUDNF-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 55383-37-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | [544311], [551871] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.